India has suspended a drugmaker’s manufacturing licence after the World Health Organization flagged contamination in its cough syrups found in the Mashall Islands and Micronesia in April, the government told the parliament on Tuesday. Indian regulators are inspecting drugmakers after cough syrups made in the country were linked to at least 89 child deaths in Gambia and Uzbekistan last year, which has damaged India’s image as the “pharmacy of the world” providing affordable drugs globally.
Recent Posts
- Lloyd’s:A new marine war risk consortium launched to support Strait of Hormuz shipping
- IRDAI constitutes expert panel to chart AI roadmap for insurance sector
- ICICI Lombard General to act as Lloyd’s local partner in India
- Public Insurance Registry:IRDAI ropes in former bureacrat Prakash Kumar as sr advisor
- Turtlemint Fintech raises Rs 397 crore from anchor investors ahead of IPO
Categories
- Articles
- Banking & Bancassurance
- Blog
- Breaking News!
- Briefs
- Climate, Environment, Renewable Energy
- Data
- Disaster & Management
- Eco/Invest/Demography
- Editorial
- Events
- Facts
- Features
- Health
- Indian News
- Intermediaries
- International News
- Interviews
- Life
- Main Menu
- Non-Life
- Pandemic
- Pension & Social Security
- Policy
- Regulation
- Reinsurance
- Risk Management
- Simple
- Technology
- Trends, Facts
- Uncategorized
- Wealth Management/ Philanthropy
- Workplace/Employee Benefits